Latest Breaking News On - Randi isaacs - Page 1 : comparemela.com

Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors

Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesRandi isaacsJosh rappaportEllen lubmanJustin moserAmerican society of clinical oncologyScientific communicationsWerewolf therapeutics incExchange commissionGlobenewswire incCompany contactHonorhealth research instituteCompany or werewolf nasdaqClinical oncologyAnnual meetingAssociate clinical investigator

Werewolf Therapeutics to Participate at the Jefferies Global Healthcare Conference

Werewolf Therapeutics to Participate at the Jefferies Global Healthcare Conference
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesEllen lubmanRandi isaacsJosh rappaportDanielj hicklinGlobenewswire incScientific communicationsWerewolf therapeutics incCompany contactCompany or werewolf nasdaqChief executive officerChief medical officerGlobal healthcare conferenceYork cityWerewolf therapeutics

Werewolf Therapeutics to Present at the Evercore ISI HealthCONx Conference – IT Business Net

Werewolf Therapeutics to Present at the Evercore ISI HealthCONx Conference – IT Business Net
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesRandi isaacsEllen lubmanDanielj hicklinCompany or werewolf nasdaqWerewolf therapeutics incScientific communicationsWerewolf therapeuticsChief executive officerChief medical officerBusiness officer werewolf

Werewolf Therapeutics to Present Clinical and Preclinical Data at the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting Seite 1

31.10.2023 - Interim, first-in-human clinical results from initial monotherapy dose-escalation cohorts in ongoing Phase 1/1b study of WTX-124 including safety and preliminary antitumor activity to be described in poster presentation.Additional posters . Seite 1

United statesSan diegoRandi isaacsCompany or werewolf nasdaqWerewolf therapeutics incSociety for immunotherapy of cancerAnnual meetingChief medical officerWerewolf therapeutics chartErewolf therapeutics kursErewolf therapeutics aktie

Werewolf Therapeutics (HOWL) to Present Clinical and Preclinical Data

Werewolf Therapeutics (HOWL) to Present Clinical and Preclinical Data
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoRandi isaacsSociety for immunotherapy of cancerWerewolf therapeutics incCompany or werewolf nasdaqWerewolf therapeuticsAnnual meetingChief medical officerFriday novemberSaturday novemberMetastatic solid tumors abstract numberSpatial analysisTumor infiltrating lymphocyte populationsSyngeneic mouse tumor models after treatmentAbstract number